MeiraGTx Holdings (MGTX) Notes Payables (2017 - 2025)

MeiraGTx Holdings (MGTX) reported Notes Payables of $24.6 million for Q4 2025, down 66.72% quarter-over-quarter from $74.1 million in Q3 2025.

MeiraGTx Holdings (MGTX) Notes Payables (2017 - 2025) Analysis & Trends

MeiraGTx Holdings has reported Notes Payables for 2 years, with the latest figure at $24.6 million in Q4 2025.

For the quarter ending Q4 2025, Notes Payables changed N/A year-over-year to $24.6 million; the trailing twelve-month figure through Dec 2025 stood at $24.6 million (changed N/A YoY), and the FY2025 full-year result was $24.6 million, changed N/A from the prior year.
Notes Payables for Q4 2025 stood at $24.6 million, down from $74.1 million in the prior quarter.
The five-year high for Notes Payables was $74.1 million in Q3 2025, with the low at $24.6 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	MeiraGTx Holdings	910.47 Mn	844.54 Mn	74.89 Mn

Download Data